Cardiac tamponade

It has been reported that acute hyperglycemia occurs in about 50% of patients hospitalised for COVID-19, while the prevalence of diabetes in the same population was about 7%. Hyperglycemia at admission in hospital seems to worsen the prognosis of COVID-19 more in people without diabetes than in people with diabetes. Hyperglycemia, in both people with or without diabetes, is an important risk factor for death in COVID-19. Please share your insights and experiences with the same.........

A 22 years girl suffering with scanty menstruation for last 3 months. Overweight Chilly pt Appetite-good Craving- milk Thirst- moderate Perspiration- moderate Stool-constipated Urine-normal Menses-regular, but scanty for last 3 months, sad and cry before menses Mind- Sentimental Hearts easily Want company Please respected doctors suggest medicine

rashes and hiccups since 8 days no H/O fever, DM, Htn what will be the management

Myocardial injury is relatively common in patients with COVID-19, accounting for 7%-23% of cases, and is associated with a higher rate of morbidity and mortality. Many cases of myocarditis in COVID-19 patients have been reported and myocarditis has been recognized as the cause of death in some COVID-19 patients. What has been your experience with such cases in your practice........

We are reading and hearing a lot about Mucormycosis these days. Here is a compiled document posted on the ICMR website. Below is the link for the same. https://www.icmr.gov.in/pdf/covid/techdoc/Mucormycosis_ADVISORY_FROM_ICMR_In_COVID19_time.pdf